Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

101 results about "Heptanone" patented technology

Heptanone may refer to the following ketones with seven carbon atoms the formula C₇H₁₄O: 2-Heptanone 5-Methyl-2-hexanone 4-Methyl-2-hexanone 3-Methyl-2-hexanone 3,3-Dimethyl-2-pentanone 4,4-Dimethyl-2-pentanone 3,4-Dimethyl-2-pentanone 3-Heptanone 2,4-Dimethyl-3-pentanone 4-Heptanone 2-Methyl-3-hexanone 4-Methyl-3-hexanone 5-Methyl-3-hexanone

Process for preparing cyclohexanone by cyclohexanol dehydrogenation

The invention discloses a process for preparing cyclohexanone by cyclohexanol dehydrogenation. Equipment for a cyclohexanol dehydrogenation procedure comprises a normal pressure or pressurized rectifying column and a cyclohexanol dehydrogenation reactor, the rectifying column is only provided with a stripping section, a column reactor is provided with a reboiler, and a cyclohexanone evaporator and a gas-liquid separator are sequentially arranged in the cyclohexanol dehydrogenation procedure. The process is used for a 100 thousand ton/year cyclohexanone production device, the concentration of methyl cyclohexanone, heptanone and analogues of the methyl cyclohexanone and the heptanone among materials in a cyclohexanone rectifying procedure and the cyclohexanol dehydrogenation procedure can be reduced from 10-13% to 1-2%, so that side reaction of dehydrogenation reaction is decreased, the quality of cyclohexanone products is improved, the service life of cyclohexanol dehydrogenation catalysts is prolonged, circulation and accumulation of the methyl cyclohexanone, the heptanone and the analogues of the methyl cyclohexanone and the heptanone in the cyclohexanone rectifying procedure and the cyclohexanol dehydrogenation procedure are decreased, and steam consumption is also greatly reduced.
Owner:长沙兴和新材料有限公司

Traditional Chinese medicinal effective part for decreasing uric acid as well as preparation method and application thereof

The invention provides a traditional Chinese medicinal effective part for decreasing uric acid as well as a preparation method and application thereof. The traditional Chinese medicinal effective part is total flavone and a diphenylheptane diarylheptanoid obtained by being extracted and separated from alpinia officinarum hance, and is prepared from the following components of 35wt% to 80 wt% of galangin, 5wt% to 14wt% of galangin-3-O-methyl ether, 1wt% to 7wt% of kaempferol-4'-O-methyl ether and 2wt% to 10wt% of 1-phenyl-7-(3'-methoxyl-4'-hydroxyl)-5-ol-3-heptanone; the sum of the components does not exceed 100 percent. The effective part prepared and obtained by the preparation method provided by the invention is definite and is high in purity. According to the whole preparation method, except for ethanol, other organic solvents are not used; the preparation method is environment-friendly and pollution-free. The industrialized mass production is easily realized in the whole production process. In-vitro and in-vivo pharmacodynamic experiments and preliminary clinical experiments all show that an alpinia-officinarum-hance effective part prepared and obtained by the preparation method provided by the invention has an obvious uric acid decreasing effect. The traditional Chinese medicinal effective part has a quite good effect on a patient suffering from hyperuricemia or gout.
Owner:武汉药谷科技开发有限公司

Technique for preparing MIBK (methyl isobutyl ketone) from acetone with liquid-phase one-step process

The invention provides a technique for preparing MIBK (methyl isobutyl ketone) from acetone with a liquid-phase one-step process. The technique comprises the following steps: hydrogen and acetone are fed into a reactor and subjected to a reaction under catalysis of gamma-Al2O3 doped hydrogen-type polystyrene cation exchange resin, and a product is delivered to an acetone recovery tower for separation; organic light components in the recovery tower are delivered to a wastewater tower, acetone is delivered back to the reactor, and heavy components at the tower bottom are delivered to a water removal tower; light components at the top of the water removal tower are delivered to an extraction tower, and a reaction product at the tower bottom is delivered to a finished product tower; purified water is adopted as an extracting agent in the extraction tower, and heavy components are delivered to the wastewater tower; MIBK is produced from a side line of the finished product tower, 2,6-dimethyl-4-heptanone and high-class ketone are produced from a tower bottom liquid. The technique is short in flow and low in energy consumption, 2,6-dimethyl-4-heptanone is co-produced, few noble metal palladium active components in a palladium supported resin catalyst are lost, stable service life as long as 7,000 h is realized, and the production cost is reduced.
Owner:湖北三里枫香科技有限公司

Alkyl-substituted quinolinone compound with side chains as well as preparation method, pharmaceutical composition and application thereof

The invention provides an alkyl-substituted quinolinone compound with side chains. The alkyl-substituted quinolinone compound has a chemical structure represented by formula I, the name of the alkyl-substituted quinolinone compound is 2-(4'-methyl-)heptane-3-methyl-4(1H)-quinolinone, the chemical formula of the alkyl-substituted quinolinone compound is C18H22NO, and the alkyl-substituted quinolinone compound is named as heptanone. The invention further provides an application of pharmaceutical composition of the compound provided by the invention in preparation of drugs for prevention and/or treatment of gastritis caused by Helicobacter pylori. According to the alkyl-substituted quinolinone compound, a first-site N of the quinolinone is not hydroxylated, and a second-site of the quinolinone is substituted by 4-methyl-heptane; the quinolinone is prepared by utilizing total synthesis; and the compound, represented by the formula I and provided by the invention, has a relatively high selective inhibition effect on the Helicobacter pylori and is an efficient proton pump inhibitor, so that a possibility for developing a novel drug for treating the gastritis caused by the Helicobacter pylori is provided.
Owner:CHONGQING UNIV OF TECH

Preparation method and application of cyclic ether type diaryl heptane in juglans regia

The invention belongs to the technical field of medicines, relates to a novel diaryl heptane compound extracted from cortex juglandis mandshuricae, and discloses a method for preparing the compound and application. The specific preparation process comprises the following steps: performing alcohol extraction method, organic solvent extraction method, purification and enrichment of a Girard reagent, silica gel column chromatography separation, preparative HPLC separation and the like on cortex juglandis mandshurica to obtain one cyclic ether type diaryl heptane compound named as 3 ', 4'-epoxy-1-(4 '-methoxyphenyl)-7-(2' ', 6'-dihydroxy-3 ''-methoxyphenyl)-3-heptanone, and further comprises the following steps of: performing column chromatography on the cyclic ether type diaryl heptane compound to obtain the 3 ', 4'-epoxy-1-(4 '-methoxyphenyl)-7-(2' ', 6'-dihydroxy-3 ''-methoxyphenyl)-3-heptanone. The molecular formula of the compound is C21H24O6. In-vitro anti-tumor activity research shows that the compound has a certain inhibition effect on human cervical cancer cells Hela and human liver cancer cells HepG-2. The method for preparing the diaryl heptane compound is clear and controllable in operation, and the obtained compound is few in impurity and high in purity and has the application prospect of being developed into anti-tumor drugs.
Owner:HEILONGJIANG UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products